83 related articles for article (PubMed ID: 11935677)
1. [Assessment of p53 dependent apoptosis in glia-derived tumors of the brain].
Kaczmarczyk R; Słodziński H; Trojanowski T; Polz-Dacewicz M
Neurol Neurochir Pol; 2001; 35 Suppl 5():30-3. PubMed ID: 11935677
[TBL] [Abstract][Full Text] [Related]
2. [Mutations of p53 gene in 41 cases of human brain gliomas].
Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC
Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the p53 gene in gliomas from Malay patients.
Jafri A; Aziz MY; Ros S; Nizam I
Med J Malaysia; 2003 Jun; 58(2):236-42. PubMed ID: 14569744
[TBL] [Abstract][Full Text] [Related]
4. Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status.
Clark AJ; Dos Santos WG; McCready J; Chen MY; Van Meter TE; Ware JL; Wolber SB; Fillmore H; Broaddus WC
J Neurosurg; 2007 Sep; 107(3):586-92. PubMed ID: 17886559
[TBL] [Abstract][Full Text] [Related]
5. Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas.
Iwadate Y; Fujimoto S; Tagawa M; Namba H; Sueyoshi K; Hirose M; Sakiyama S
Int J Cancer; 1996 Jun; 69(3):236-40. PubMed ID: 8682593
[TBL] [Abstract][Full Text] [Related]
6. Sporadic p53 mutations and absence of ras mutations in glioblastomas.
Gömöri E; Dóczi T; Pajor L; Matolcsy A
Acta Neurochir (Wien); 1999; 141(6):593-9. PubMed ID: 10929724
[TBL] [Abstract][Full Text] [Related]
7. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
[TBL] [Abstract][Full Text] [Related]
8. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
Frankel RH; Bayona W; Koslow M; Newcomb EW
Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the TP53 gene in human gliomas.
Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
[TBL] [Abstract][Full Text] [Related]
10. The analysis of p53 tumor suppressor gene in pineal parenchymal tumors.
Tsumanuma I; Sato M; Okazaki H; Tanaka R; Washiyama K; Kawasaki T; Kumanishi T
Noshuyo Byori; 1995 Mar; 12(1):39-43. PubMed ID: 7795728
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations in malignant gliomas.
Li Y; Millikan RC; Carozza S; Newman B; Liu E; Davis R; Miike R; Wrensch M
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):303-8. PubMed ID: 9568785
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the p53 gene in postradiation sarcoma.
Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
[TBL] [Abstract][Full Text] [Related]
13. Absence of p53 autoantibodies in sera from glioma patients.
Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
[TBL] [Abstract][Full Text] [Related]
14. Ethnicity delineates different genetic pathways in malignant glioma.
Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutations in malignant astrocytomas.
Biernat W; Debiec-Rychter M; Kordek R; Liberski PP
Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927
[TBL] [Abstract][Full Text] [Related]
16. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 and prognosis in children with malignant gliomas.
Pollack IF; Finkelstein SD; Woods J; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Boyett JM; Finlay JL; Sposto R;
N Engl J Med; 2002 Feb; 346(6):420-7. PubMed ID: 11832530
[TBL] [Abstract][Full Text] [Related]
18. PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
Rasheed BK; Stenzel TT; McLendon RE; Parsons R; Friedman AH; Friedman HS; Bigner DD; Bigner SH
Cancer Res; 1997 Oct; 57(19):4187-90. PubMed ID: 9331072
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
20. [p53 gene mutations in brain tumors].
Koga H; Kumanishi T
No To Shinkei; 1995 Sep; 47(9):845-55. PubMed ID: 7546933
[No Abstract] [Full Text] [Related]
[Next] [New Search]